In 1974, Asahi Kasei Medical successfully developed an innovative dialyzer using the world's first cuprammonium cellulosic hollow-fiber membrane (Bemberg HF membrane). Since then, Asahi Kasei Medical has established a leading position as a supplier of dialyzers to more than 60 countries worldwide.
In addition to dialyzers, Asahi Kasei Medical has applied its core technologies for membrane separation using hollow fibers and absorption in various areas of healthcare and industry. The product lineup includes devices for the treatment of immunologic or intractable diseases, leukocyte reduction filters to prevent adverse effects associated with blood transfusion, and virus removal filters used in biopharmaceutical production for export worldwide. Asahi Kasei Medical, a pioneer in blood purification, will continue to contribute to global healthcare with its unique technologies in close collaboration with members of the Asahi Kasei Group.
 |
|||||
 |
 |
 |
 |
||
|
 |
 |
 |
||
1974
Successful development of the world's first dialyzer using a Bemberg™ hollow-fiber membrane
Asahi Kasei Medical was established in 1974 as a new company in the Asahi Kasei Group, a Japanese manufacturer of chemical products. With contribution to healthcare as its goal, the first step was the production of the Bemberg hollow-fiber membrane and its application in the development of an artificial kidney. More>>
1982
Development of the Plasmaflo™ AP plasma separator
- Blood purification products: new core product line in addition to dialyzers
After dialyzers became widespread in general use, Asahi Kasei Medical started to investigate the potential application of its hollow-fiber membrane to other products. More>>
1985
Launch of the Sepacell™ R leukocyte reduction filter
- High evaluation in the Mediterranean region triggered international distribution
In 1985, Asahi Kasei Medical pioneered the development of leukocyte reduction filters for blood used in transfusions. Thalassemia patients played a key role in their commercialization. More>>
2001
Development of Cellsorba™ for inflammatory bowel disease (IBD)
- Apheresis technology contributing to treatment of intractable diseases
From its experience with Sepacell, Asahi Kasei Medical obtained valuable know-how on ultrafine nonwoven fabric leukocyte reduction filters and applied it to the treatment of intractable diseases, launching Cellsorba E, an absorption-type apheresis column, in 2001. More>>
2004-2005
Corporate name change
Planova™ virus removal filter business transferred from Asahi Kasei Pharma Corp.
- Synergy of Asahi Kasei Group expertise to become a new-generation medical corporation
In October, 2004, the former company name Asahi Medical Co., Ltd. was changed to Asahi Kasei Medical Co., Ltd. More>>
2007
As of October 1, 2007, Asahi Kasei Medical Co., Ltd. has integrated the dialyzer business section of Kuraray Medical Co., Ltd., and has divided into two independent corporations: Asahi Kasei Kuraray Medical Co., Ltd, and Asahi Kasei Medical Co., Ltd.
Asahi Kasei Medical and Kuraray Medical's products and technologies complement one another to afford a wider range of options to optimize therapy to match the specific needs of each patient. More>>
Plasmaflo, Sepacell, Cellsorba and Planova are trademarks of Asahi Kasei Kuraray Medical Co.,Ltd./Asahi Kasei Medical Co., Ltd.
